Retirement Systems Of Alabama Gilead Sciences, Inc. Transaction History

Retirement Systems Of Alabama

$26.3 Billion
Q3 2024

A detailed history of Retirement Systems Of Alabama transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Retirement Systems Of Alabama holds 761,854 shares of GILD stock, worth $71.9 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

761,854

Previous 812,344 6.22%

Holding current value

$71.9 Million

Previous $55.7 Million 14.58%

% of portfolio

0.24%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 06, 2024	SELL	$66.59 - $83.99 $3.36 Million - $4.24 Million	-50,490 Reduced 6.22%	761,854 $63.9 Million
Q2 2024 Jul 24, 2024	SELL	$63.15 - $72.88 $2.04 Million - $2.36 Million	-32,325 Reduced 3.83%	812,344 $55.7 Million
Q1 2024 Apr 30, 2024	BUY	$71.58 - $87.29 $40.8 Million - $49.8 Million	570,053 Added 207.58%	844,669 $61.9 Million
Q4 2023 Feb 05, 2024	SELL	$73.27 - $83.09 $521,682 - $591,600	-7,120 Reduced 2.53%	274,616 $22.2 Million
Q3 2023 Nov 06, 2023	SELL	$73.94 - $80.67 $129,912 - $141,737	-1,757 Reduced 0.62%	281,736 $21.1 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $6.47 Million - $7.38 Million	-85,086 Reduced 23.08%	283,493 $21.8 Million
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $2.57 Million - $2.93 Million	-33,233 Reduced 8.27%	368,579 $30.6 Million
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $903,203 - $1.3 Million	-14,493 Reduced 3.48%	401,812 $34.5 Million
Q3 2022 Nov 04, 2022	SELL	$59.54 - $68.01 $7.27 Million - $8.3 Million	-122,038 Reduced 22.67%	416,305 $25.7 Million
Q2 2022 Aug 03, 2022	SELL	$57.72 - $65.01 $912,899 - $1.03 Million	-15,816 Reduced 2.85%	538,343 $33.3 Million
Q1 2022 Apr 20, 2022	BUY	$57.92 - $72.58 $659,998 - $827,049	11,395 Added 2.1%	554,159 $32.9 Million
Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $638,289 - $724,470	-9,838 Reduced 1.78%	542,764 $39.4 Million
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $1.66 Million - $1.79 Million	-24,476 Reduced 4.24%	552,602 $38.6 Million
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $864,715 - $944,824	-13,624 Reduced 2.31%	577,078 $39.7 Million
Q1 2021 Apr 15, 2021	SELL	$60.0 - $68.46 $1.61 Million - $1.84 Million	-26,811 Reduced 4.34%	590,702 $38.2 Million
Q4 2020 Jan 26, 2021	BUY	$56.65 - $64.55 $967,412 - $1.1 Million	17,077 Added 2.84%	617,513 $36 Million
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $423,149 - $532,037	-6,814 Reduced 1.12%	600,436 $37.9 Million
Q2 2020 Jul 23, 2020	SELL	$72.34 - $84.0 $3.75 Million - $4.36 Million	-51,902 Reduced 7.87%	607,250 $46.7 Million
Q1 2020 Apr 20, 2020	SELL	$62.63 - $80.22 $34 Million - $43.5 Million	-542,869 Reduced 45.16%	659,152 $49.3 Million
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $87,623 - $96,383	1,422 Added 0.12%	1,202,021 $78.1 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $2.39 Million - $2.64 Million	38,282 Added 3.29%	1,200,599 $76.1 Million
Q2 2019 Jul 09, 2019	BUY	$61.87 - $69.38 $7.87 Million - $8.82 Million	127,184 Added 12.29%	1,162,317 $78.5 Million
Q1 2019 Apr 15, 2019	BUY	$62.53 - $70.05 $1.15 Million - $1.28 Million	18,313 Added 1.8%	1,035,133 $67.3 Million
Q3 2018 Oct 24, 2018	SELL	$71.28 - $78.92 $868,760 - $961,876	-12,188 Reduced 1.18%	1,016,820 $78.5 Million
Q2 2018 Jul 17, 2018	SELL	$64.88 - $75.68 $1.02 Million - $1.19 Million	-15,785 Reduced 1.51%	1,029,008 $72.9 Million
Q1 2018 Apr 27, 2018	SELL	$72.84 - $88.8 $527,434 - $643,000	-7,241 Reduced 0.69%	1,044,793 $78.8 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $38,492 - $45,184	-541 Reduced 0.05%	1,052,034 $75.4 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $75.9 Million - $90 Million	1,052,575	1,052,575 $85.3 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.

Account

Retirement Systems Of Alabama Gilead Sciences, Inc. Transaction History